tabuk pharmaceuticals dammam plant

Activity value 61 saudi arabia Buyer,Last transaction date: 2020-11-30

Overview
Import data
Partners
HS Codes
Products
Areas
Ports

Trade trend analysis

Mon | Year

Number of Transactions Quantity Weight

The above chart presents the market trend analysis for tabuk pharmaceuticals dammam plant from 2019 to 2020. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2020, the company has completed 4 transactions, with a transaction quantity of 4 and a transaction weight of 0.

Year Transactions Quantity Weight
2019 0 0 0
2020 4 4 0

Bill of lading data

< 1/4 >

Trade date 2020/11/30 B/L No. 4m5uma9h5jorr
Suppliers gland pharma Buyers tabuk pharmaceuticals dammam plant
POLs hyderabad PODs dammam
Supply area India Purchas area Saudi Arabia
Weight —— Amount 20.005
Hs code 29420090 Product tags hydrochloride,tirofiban
Product description TIROFIBAN HYDROCHLORIDE WS ( MEIS S.NO:1 813) (QTY: 100 MG) Expand

Trade date 2020/11/30 B/L No. 4m5uma9h5jorr
Suppliers gland pharma Buyers tabuk pharmaceuticals dammam plant
POLs hyderabad PODs dammam
Supply area India Purchas area Saudi Arabia
Weight —— Amount 5.001
Hs code 29420090 Product tags related compound b,tirofiban
Product description TIROFIBAN RELATED COMPOUND B WS ( MEIS S .NO:1813) (QTY: 5 MG) Expand

Trade date 2020/11/30 B/L No. ——
Suppliers gland pharma ltd. Buyers tabuk pharmaceuticals dammam plant
POLs hyderabad PODs dammam
Supply area India Purchas area Saudi Arabia
Weight —— Amount 19.85
Hs code 29420090 Product tags hydrochloride,tirofiban
Product description TIROFIBAN HYDROCHLORIDE WS ( MEIS S.NO:1 813) (QTY: 100 MG Expand

Trade date 2020/11/30 B/L No. 4m5uma9h5jorr
Suppliers gland pharma Buyers tabuk pharmaceuticals dammam plant
POLs hyderabad PODs dammam
Supply area India Purchas area Saudi Arabia
Weight —— Amount 5.001
Hs code 29420090 Product tags related compound a,tirofiban
Product description TIROFIBAN RELATED COMPOUND A WS ( MEIS S .NO:1813) (QTY: 5 MG) Expand

Partners

Total 2

Rank Company Transactions Per Detail
1 gland pharma indiabuyer,they trade on 2020-11-30 3 75.00% >
2 gland pharma ltd. indiasupplier,they trade on 2020-11-30 1 25.00% >

Products

Total 4

Products Transactions Per Detail
tirofiban
4 100% >
hydrochloride
2 50% >
related compound a
1 25% >
related compound b
1 25% >

Hscode rank

Total 1

HSCode Name Transactions Per Detail
HS 29420090 4 100% >

tabuk pharmaceuticals dammam plant is saudi arabia Buyer, and primarily engages in the import and export business of products such as tirofiban，hydrochloride，related compound a. According to the 52wmb.com global trade database, as of 2020-11-30, the company has completed 4 international trades, The core products include HS29420090 etc, and its main trading partners are gland pharma，gland pharma ltd.. These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing. They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.

The trade data displayed on tabuk pharmaceuticals dammam plant is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info

Email Hunting Tool

Employee emails